Search results for "Lung"

showing 10 items of 2389 documents

Solid-liquid interactions in human lung system enhanced by yttrium and REE distribution in Broncho-alveolar lavages.

2010

human lung systemSolid-liquid interactionsSettore GEO/08 - Geochimica E Vulcanologia
researchProduct

Genome-wide association analysis identifies six new loci associated with forced vital capacity

2014

Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P < 5 × 10−8) with FVC in or near EFEMP1, BMP6, MIR129-2–HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispanic in…

idiopathic pulmonary-fibrosislung-function gene-expressionrespiratory systemrespiratory tract diseases
researchProduct

Lung hyperinflation in COPD attenuates airway distension by deep inspiration (DI) measured with HRCT

2005

imaging lung inflationSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

First-Line Treatments for Extensive-Stage Small-Cell Lung Cancer With Immune Checkpoint Inhibitors Plus Chemotherapy: A Network Meta-Analysis and Cos…

2022

BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy were unlikely to be considered cost-effective compared with chemotherapy as the first-line treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) in China due to its high costs. However, the cost-effectiveness of the comparison between the regimens of ICIs plus chemotherapy were remained unclear yet. The aim of this study was to evaluate the efficacy and cost-effectiveness of ICIs plus chemotherapy as the first-line treatment for ES-SCLC from the perspective of the Chinese healthcare system.MethodsA network meta-analysis (NMA) was conducted to indirect compare the clinical benefits between the ICIs plus che…

immune checkpoint inhibitorsCancer ResearchOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogenschemotherapyextensive-stage small-cell lung cancercost-effectivenessfirst-line treatmenthealth care economics and organizationsRC254-282Original ResearchFrontiers in Oncology
researchProduct

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

2022

Simple Summary Moving from the achievements of immune checkpoint inhibitors in metastatic lung cancer, the great promise of immunotherapy in resectable early-stage is to make a disease, often lethal until now for frequent post-surgery relapses, more curable. This review focuses on role of immunotherapy in early-stage non-small cell lung cancer. We summarize biological rationale, findings from clinical trials of adjuvant and neoadjuvant immune checkpoint inhibitors, questions about biomarkers and choice of endpoints, aiming to provide up-to-date information useful for clinical decision making. Lung cancer is the leading cause of cancer-related death worldwide. Since prognosis of early-stage …

immune checkpoint inhibitorsCancer Researchlung cancernon-small-cell lung carcinoma (NSCLC)OncologyadjuvantSettore MED/06 - Oncologia Medicaneoadjuvantadjuvant; immune checkpoint inhibitors; immunotherapy; lung cancer; neoadjuvant; non-small-cell lung carcinoma (NSCLC);immune checkpoint inhibitorimmunotherapy
researchProduct

Precision Measurement of the Mass and Lifetime of the Xi(-)(b) Baryon

2016

We report on measurements of the mass and lifetime of the Ξ[- over b] baryon using about 1800 Ξ[- over b] decays reconstructed in a proton-proton collision data set corresponding to an integrated luminosity of 3.0  fb[superscript -1] collected by the LHCb experiment. The decays are reconstructed in the Ξ[- over b] → Ξ[0 over c]π[superscript -], Ξ[0 over c] → pK[superscript -]K[superscript -]π[superscript +] channel and the mass and lifetime are measured using the Λ[0 over b] → Λ[+ over c]π[superscript -] mode as a reference. We measure M(Ξ[- over b] - M(Λ[0 over b]) = 178.36 ± 0.46 ± 0.16  MeV/c[superscript 2], (τ[subscript Ξ[- over b]/τ[subscript Λ[0 over b]) = 1.089 ± 0.026 ± 0.011, where…

inclusive weak decays; discarding 1/N(C); quark-model; beaty; charm; ruleFísica nuclearLHCb - Abteilung HofmannQCParticle Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experiment
researchProduct

A challenging case of chorioretinitis and skin lesions in a lung transplant recipient

2018

no

infection and infectious agentsmedicine.medical_specialtyinfectious diseaseclinical research/practicecomplication: infectioulung transplantation/pulmonologyBiopsymedicineImmunology and AllergybiopsyPharmacology (medical)Lung transplant recipientTransplantationmedicine.diagnostic_testinfection and infectious agentbusiness.industryChorioretinitisantibiotic: antifungalmedicine.diseaseinfection and infectious agents - fungalDermatologycomplication: infectiousAntibiotics antifungalInfectious disease (medical specialty)Skin lesionbusinessantibiotic: antifungal; biopsy; clinical research/practice; complication: infectious; infection and infectious agents; infection and infectious agents - fungal; infectious disease; lung transplantation/pulmonology; Immunology and Allergy; Transplantation; Pharmacology (medical)American Journal of Transplantation
researchProduct

Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized …

2008

Summary Purpose A phase III randomized trial was carried out to compare two schedules of the vinorelbine (VNR)–cisplatin (CDDP) regimen in patients with locally advanced unresectable poor prognosis stage IIIB or metastatic stage IV non-small cell lung cancer. The primary endpoints were overall survival (OS) and analysis of toxicity, while secondary endpoints included response rates, time-to-progression (TTP) and quality of life (QoL). Patients and methods Eligible patients were randomized to receive: (a) VNR 25 mg/m 2 on day 1, 8 and 15 plus CDDP 100 mg/m 2 on day 1 every 4 weeks or (b) VNR 30 mg/m 2 on day 1 and 8 plus CDDP 80 mg/m 2 on day 1 every 3 weeks. All patients were chemotherapy-n…

inorganic chemicalsPulmonary and Respiratory MedicineAdultMaleCancer Researchmedicine.medical_specialtyRandomizationLung NeoplasmsVinorelbineVinblastineGastroenterologyStatistics Nonparametriclaw.inventionRandomized controlled triallawInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesLung cancerProspective cohort studyneoplasmsAgedNeoplasm StagingChi-Square Distributionbusiness.industryVinorelbineMiddle Agedmedicine.diseaseVinblastineSurgeryRegimenLogistic ModelsTreatment OutcomeOncologyItalyDisease ProgressionQuality of LifeFemaleCisplatinbusinessFebrile neutropeniamedicine.drugLung cancer (Amsterdam, Netherlands)
researchProduct

IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease

2022

ObjectiveSystemic sclerosis (SSc) mortality is extremely variable in its internal organ involvement. Pulmonary fibrosis occurs in up to 30% of the cases. Animal models provide evidence that IL-33 is able to induce both cutaneous and pulmonary fibrosis via increased IL-13 and in SSc patients the levels of IL-33 correlate with skin fibrosis. Our aim was to test whether both IL-33 and IL-13 are higher in patients with diffuse SSc and interstitial lung disease (SSc-ILD) compared to SSc patients without ILD and healthy controls.MethodsSerum levels of IL-13 and IL-33 were measured in 30 SSc patients with diffuse disease and 30 healthy controls by enzyme-linked immunosorbent assay. The extent of p…

interstitial lung diseaseMedicine (General)R5-920interleukinsintegumentary systemsystemic sclerosisIL-13IL-13; IL-33; interleukins; interstitial lung disease; systemic sclerosisIL-33General Medicinerespiratory systemskin and connective tissue diseases
researchProduct

Nuclear Charge Radii of the Nickel Isotopes $^{58-68,70}$Ni

2022

Collinear laser spectroscopy is performed on the nickel isotopes Ni58-68,70, using a time-resolved photon counting system. From the measured isotope shifts, nuclear charge radii Rc are extracted and compared to theoretical results. Three ab initio approaches all employ, among others, the chiral interaction NNLOsat, which allows an assessment of their accuracy. We find agreement with experiment in differential radii δ⟨rc2⟩ for all employed ab initio methods and interactions, while the absolute radii are consistent with data only for NNLOsat. Within nuclear density functional theory, the Skyrme functional SV-min matches experiment more closely than the Fayans functional Fy(Δr,HFB). Collinear …

isotoopitNuclear Theorynucl-th[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]tiheysfunktionaaliteoriaNuclear TheoryFOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]nucl-exNuclear Theory (nucl-th)Nuclear Physics - TheoryNuclear Physics - ExperimentPräzisionsexperimente - Abteilung BlaumNuclear Experiment (nucl-ex)ydinfysiikkanikkeliNuclear Experiment
researchProduct